BRN

0.00%

23.0¢ brainchip holdings ltd

I have to agree, but very strange with some of the partners we...

First 19414 Last

Share
Profile

Follow
Molkir

38 Posts.

4

08/02/23

14:26

Post #: 66136698
Share

Originally posted by Jfibbo: ↑

Shares on Issue amount is a big contributing factor here. At 1/10 our shares theyve maintained what is a limited dilution model at this point.
Our dilution here hasnt helped the SP but if BRN gets to 20B market cap then the dilution means nil.
Full disclosure - I hold WBT, but its been a fascinating journey for these 2 stocks.
Does WBT have some massive future dilution events to reach its goals?
Ya have to remember that it buzzed up to$11.50 first listed year so many would be in the red here from 2011 - 2013 if still holding.
I dont contribute on its forums but I do chart it. Theres 100% move to ATH.
BRN has over 300% to its ATH.
Both companies are in the right space, WBT should on paper see more volatility in SP given its SOI but how high can it go?
To answer your question IMO BRN is cheap even if you use only Patent value & current licenses value to measure - True share dollar value wont be realised financially until revenue kicks in and fundamentals start to line up. 2024 - 2025. Theres many SP kickers like a Nasdaq listing, product release announcements, further patents and continued staff growth/ office openings, that will be realised at some point.
Which stock has greater capacity for large SP - BRN in my opinion. The shear volume of use cases expanding with each AKD model is exponential and limitless. The IP model is extremely profitable once its established. When revenue hits, I think jumps will occur in 9 figure lumps, not as weve experienced to date. If ONLY the dozen or more partners sign licenses, that a dozen price sensitive announcements. That would put us up there with WBT SP in my opinion. So its just a waiting game here.

Expand

I have to agree, but very strange with some of the partners we have that BRN is stuck around the 65c mark and WBT is flying around $5.50 - $6.00!!!!!!!???? I get what you're saying with the amount of shares, but the price difference is crazy to me, anyway I definitely think (could be silly!) but just keep buying more BRN will come good

BRN Price at posting: 63.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 1,493 more messages in this thread...

First 19414 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $451.3M

Open	High	Low	Value	Volume
23.0¢	24.0¢	21.5¢	$2.863M	12.69M

Buyers (Bids)

No.	Vol.	Price($)
6	136498	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	444756	13

View Market Depth

No.	Vol.	Price($)
4	86498	0.230
3	155000	0.225
16	439886	0.220
14	751341	0.215
35	871743	0.210

Price($)	Vol.	No.
0.235	360988	11
0.240	791244	17
0.245	612347	15
0.250	151787	5
0.255	132485	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

BRN (ASX) Chart

I have to agree, but very strange with some of the partners we...

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I have to agree, but very strange with some of the partners we...

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News